Abstract
This Perspective focuses on the α1D-adrenergic receptor (AR), the often neglected sibling of the α1-AR family. This neglect is due in part to its poor cell-surface expression. However, it has recently been shown that dimerization of the α1D-AR with either the α1B-AR or the β2-AR increases α1D-AR cell-surface expression, and in this issue of Molecular Pharmacology, Hague et al. (p. 45) demonstrate that dimerization of the α1D-AR with the α1B-AR not only leads to increased cell-surface expression but also results in the formation of a novel functional entity.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.